Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 JAK2V617F mutational frequency in polycythemia vera: 100%, >90%, less?

Literature DB >> 16990780

JAK2V617F mutational frequency in polycythemia vera: 100%, >90%, less?

S Verstovsek, R T Silver, N C P Cross, A Tefferi.

Abstract

Entities: Disease Gene

Mesh：

Substances：

Year: 2006 PMID： 16990780 DOI： 10.1038/sj.leu.2404379

Source DB: PubMed Journal: Leukemia ISSN： 0887-6924 Impact factor: 11.528

Keyword Cloud
Cited

× No keyword cloud information.

12 in total

1. Design and evaluation of a real-time PCR assay for quantification of JAK2 V617F and wild-type JAK2 transcript levels in the clinical laboratory.

Authors: Jason D Merker; Carol D Jones; Stephen T Oh; Iris Schrijver; Jason Gotlib; James L Zehnder
Journal: J Mol Diagn Date: 2009-12-03 Impact factor: 5.568

2. JAK2 V617F and the evolving paradigm of polycythemia vera.

Authors: Robert T Means
Journal: Korean J Hematol Date: 2010-06-30

Review 3. Classification and diagnosis of myeloproliferative neoplasms according to the 2008 World Health Organization criteria.

Authors: Martha Wadleigh; Ayalew Tefferi
Journal: Int J Hematol Date: 2010-02-27 Impact factor: 2.490

4. JAK2S523L, a novel gain-of-function mutation in a critical autoregulatory residue in JAK2V617F- MPNs.

Authors: Friederike Pastore; Aishwarya Krishnan; Henrik M Hammarén; Olli Silvennoinen; Benedict Yan; Ross L Levine
Journal: Blood Adv Date: 2020-09-22

5. Genetic Characteristics of Polycythemia Vera and Essential Thrombocythemia in Korean Patients.

Authors: Eun-Hyung Yoo; Kyung-Jin Park; Hong-Hee Won; Jun-Hee Park; Jong-Ho Park; Seung-Tae Lee; Hee-Jin Kim; Soo-Mee Bang; Hyun-Sook Chi; Chul Won Jung; Sun-Hee Kim; Hongseok Yun; Choong-Hyun Sun; Inho Park; Seungmook Lee; Clarence Lee; Barry Merriman; Raymond Luo; Eileen Hwee Hong Tan; Keun-Joon Park; Na-Kyung Yoo; Jason J Kang; Jong-Won Kim
Journal: J Clin Lab Anal Date: 2016-05-02 Impact factor: 2.352

6. Imatinib mesylate therapy for polycythemia vera: final result of a phase II study initiated in 2001.

Authors: Roberto H Nussenzveig; Jorge Cortes; Matjaz Sever; Alfonso Quintás-Cardama; Pat Ault; Taghi Manshouri; Carlos Bueso-Ramos; Josef T Prchal; Hagop Kantarjian; Srdan Verstovsek
Journal: Int J Hematol Date: 2009-05-30 Impact factor: 2.490

7. Development and inter-laboratory validation of unlabeled probe melting curve analysis for detection of JAK2 V617F mutation in polycythemia vera.

Authors: Zhiyuan Wu; Hong Yuan; Xinju Zhang; Weiwei Liu; Jinhua Xu; Wei Zhang; Ming Guan
Journal: PLoS One Date: 2011-10-20 Impact factor: 3.240